NeuroOne Medical Technologies 

$3.29
28
-$0.02-0.45% Thursday 20:00

Statistics

Day High
3.34
Day Low
3.15
52W High
6.96
52W Low
3.11
Volume
47,000
Avg. Volume
-
Mkt Cap
166.23M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-0.58
-0.37
-0.15
0.06
Expected EPS
-0.583333
Actual EPS
N/A

Financials

-39.62%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
18.2MRevenue
-7.21MNet Income

Analyst Ratings

4.75Average Price Target
The highest estimate is 8.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NMTC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap101.56B
Medtronic is a major player in the medical device industry, offering products that compete directly with NeuroOne's neurotechnology solutions.
Abbott Laboratories
ABT
Mkt Cap153.99B
Abbott Laboratories provides a wide range of medical devices, including neurostimulation devices that compete with NeuroOne's offerings.
Smith & Nephew
SNN
Mkt Cap12.72B
Smith & Nephew operates in the medical technology sector, offering products that can compete in the neurosurgical space.
Boston Scientific
BSX
Mkt Cap67.32B
Boston Scientific Corporation offers innovative medical solutions, including neuromodulation devices that rival NeuroOne's technologies.
Stryker
SYK
Mkt Cap118B
Stryker Corporation is a leading medical technology company with products that compete in the neurotechnology and neurosurgical markets.
Zimmer Biomet
ZBH
Mkt Cap17.02B
Zimmer Biomet Holdings, Inc. provides various medical devices that, while primarily focused on orthopedics, also ventures into areas that can compete with NeuroOne.
Johnson & Johnson
JNJ
Mkt Cap549.78B
Johnson & Johnson, through its medical devices segment, offers products that can compete across a broad range of medical device categories, including neuro.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical, Inc. specializes in robotic-assisted surgery, a field that intersects with NeuroOne's focus on advanced surgical technologies.
Edwards Lifesciences
EW
Mkt Cap50.3B
Edwards Lifesciences Corporation is known for its heart disease treatments but also invests in technology that could compete in the broader medical device market.
Integra Lifesciences
IART
Mkt Cap1.36B
Integra LifeSciences Holdings Corporation offers products for neurosurgery, directly competing with NeuroOne's neurotechnology solutions.

About

NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.
Show more...
CEO
Mr. David A. Rosa M.D.
Employees
17
Country
United States
ISIN
US64130M3088

Listings

0 Comments

Share your thoughts

FAQ

What is NeuroOne Medical Technologies stock price today?
The current price of NMTC is $3.29 USD — it has decreased by -0.45% in the past 24 hours. Watch NeuroOne Medical Technologies stock price performance more closely on the chart.
What is NeuroOne Medical Technologies stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange NeuroOne Medical Technologies stocks are traded under the ticker NMTC.
Is NeuroOne Medical Technologies stock price growing?
NMTC stock has fallen by -0.9% compared to the previous week, the month change is a -10.84% fall, over the last year NeuroOne Medical Technologies has showed a -16.92% decrease.
What is NeuroOne Medical Technologies market cap?
Today NeuroOne Medical Technologies has the market capitalization of 166.23M
When is the next NeuroOne Medical Technologies earnings date?
NeuroOne Medical Technologies is going to release the next earnings report on August 19, 2026.
What were NeuroOne Medical Technologies earnings last quarter?
NMTC earnings for the last quarter are -0.25 USD per share, whereas the estimation was -0.23 USD resulting in a -10.29% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is NeuroOne Medical Technologies revenue for the last year?
NeuroOne Medical Technologies revenue for the last year amounts to 18.2M USD.
What is NeuroOne Medical Technologies net income for the last year?
NMTC net income for the last year is -7.21M USD.
How many employees does NeuroOne Medical Technologies have?
As of June 22, 2026, the company has 17 employees.
In which sector is NeuroOne Medical Technologies located?
NeuroOne Medical Technologies operates in the Health & Wellness sector.
When did NeuroOne Medical Technologies complete a stock split?
The last stock split for NeuroOne Medical Technologies was on April 15, 2026 with a ratio of 1:6.
Where is NeuroOne Medical Technologies headquartered?
NeuroOne Medical Technologies is headquartered in Eden Prairie, United States.